Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Rivaroxaban in Anterior Myocardial Infarction
NCT05744804Unknown
- Sponsor
- Sohag University
- Start
- Mar 2023
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of rivaroxaban in myocardial infarction (MI) (2 arms), sponsored by Sohag University. Primary endpoints: Major adverse cardiovascular event at 10 months, Left ventricular function at 10 months and 2 more. Status: unknown.
02
Drugs
rivaroxaban
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on NCT05744804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05744804.